Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Dec;48(6):897-901.
doi: 10.1002/mus.23846. Epub 2013 Apr 21.

Creatine kinase response to high-intensity aerobic exercise in adult-onset muscular dystrophy

Affiliations

Creatine kinase response to high-intensity aerobic exercise in adult-onset muscular dystrophy

Søren P Andersen et al. Muscle Nerve. 2013 Dec.

Abstract

Introduction: We investigated the effect of high-intensity exercise on plasma creatine kinase (CK) in patients with muscular dystrophies.

Methods: Fourteen patients with Becker (BMD), facioscapulohumeral (FSHD), or limb-girdle type 2 (LGMD2) muscular dystrophy, and 8 healthy subjects performed 5 cycling tests: an incremental max test, and tests at 65%, 75%, 85%, and 95% of maximal oxygen uptake (VO2max ). Heart rate and oxygen consumption were measured during the tests, and plasma CK was measured before, immediately after, and 24 hours after exercise.

Results: All subjects were able to perform high-intensity exercise at the different levels. In patients with LGMD2 and FSHD, CK normalized 24 hours after exercise compared with the pre-exercise value, whereas those with BMD and healthy controls had elevated CK values 24 hours after exercise.

Conclusions: The findings suggest that high-intensity exercise is generally well tolerated in patients with LGMD2 and FSHD, whereas those with BMD may be more prone to exercise-induced damage.

Keywords: Becker muscular dystrophy; creatine kinase; facioscapulohumeral muscular dystrophy; limb-girdle muscular dystrophy type 2; muscular dystrophy.

PubMed Disclaimer

Publication types

Substances

Supplementary concepts